Investors & strategic partners

A category-defining instrument, in one company’s hands what an acquirer or partner would be looking at

HANS Korea created the nickel-titanium brush for peri-implantitis in 2010, patented it in 2011, and has manufactured it without interruption since. Fifteen years on, the NiTi Brush is the instrument that independent research groups use as the mechanical baseline when they test newer decontamination technologies — and it is still made by the company that designed it.

15Years in production
17Verified publications
65Independent investigators
30Institutions in 14 countries
18Countries supplied
3Granted patents
  • Named by the manufacturer in independent peer-reviewed work — “a titanium brush (Hans Korea Co., Ltd.)”, “NANO NiTi Brush, HANS KOREA CO., Ltd” — including multicentre randomised trials in Sweden, Spain and Italy. See the published evidence.
  • Regulatory depth — CE Class IIa (MDD, valid to 31 December 2028 under Regulation (EU) 2023/607), MDR application filed with the on-site audit completed in June 2026, FDA establishment registration and device listing, MHLW registration in Japan, IFU in 19 languages. See the MDR timeline.
  • Manufacturing in-house — production relocated in 2024 to a facility built for MDR-conformant manufacture; tooling, process and quality system owned by the company.
  • An established channel — authorised distributors in 18 countries across Europe, Asia and the Americas, with the regulatory pack and training programme already in use.
  • A growing indication — the population of implants old enough to develop peri-implantitis increases every year; see the clinical problem.

What we are open to

Licensing

Licence of the patented design and the manufacturing know-how for a defined territory or field, with technical transfer and quality-system support.

Co-development

Joint development of next-generation models, drive systems or combined mechanical-chemical protocols, building on the clinical base already published.

Investment and corporate transactions

Minority investment, strategic partnership or acquisition of the business, its intellectual property and its regulatory files. Discussed by management in confidence.

How a conversation starts

Public information about the company is on this website. Anything beyond it is shared with qualified counterparties only once a non-disclosure agreement is in place.

  1. Introduction

    Write to management with a short description of who you are and what you have in mind. No deck is needed at this stage.

  2. Non-disclosure agreement

    We put a mutual NDA in place before any non-public detail is exchanged. We can work from your template or ours.

  3. Information under NDA

    You receive the information relevant to your proposal and a call with management to answer questions.

  4. Proposal

    Structure and terms are then discussed on that basis. Everything is handled by management directly.

Confidential contact

Write to [email protected] with “Partnership” in the subject line. Such enquiries are read by the company’s management only and handled in confidence.

Prospective distributors: please use the distribution page and the contact form instead, so that your enquiry reaches the right desk.

Confidential enquiries [email protected]
Please put “Partnership” in the subject line.
CompanyHANS KOREA CO.,Ltd.
Telephone+82-31-977-2809
Address 314Ho, 107 Garam-ro 116beon-gil, Paju-si, Gyeonggi-do 10896, Republic of Korea

Nothing on this page is an offer, a solicitation or an invitation to invest. It describes the basis on which HANS Korea is willing to open a confidential discussion.